Risk Factors for Totally Implantable Central Venous Access Port-related Infection in Patients With Malignancy.
Furuhashi S, Morita Y, Ida S, Muraki R, Kitajima R, Suzuki K, Takeda M, Kikuchi H, Hiramatsu Y, Kurachi K, Shido Y, Sugimoto K, Ito H, Maekawa Y, Mineta H, Miyake H, Takeuchi H.
Furuhashi S, et al. Among authors: kitajima r.
Anticancer Res. 2021 Mar;41(3):1547-1553. doi: 10.21873/anticanres.14914.
Anticancer Res. 2021.
PMID: 33788748